Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design - Aim 3

NCT07589387 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT07589387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07589387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design - Aim 3
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
January 31, 2030
Enrollment
2,800 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabete mellitus